Anzeige
Mehr »
Login
Dienstag, 21.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Die Wachstumsgeschichte: Analysten sehen kurzfristige +37 %-Chance bei diesem europäischen Marktführer
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
320 Leser
Artikel bewerten:
(1)

Downstream Processing Market to Exceed US$ 25.4 Billion by 2030: Reveals Transparency Market Research, Inc.

  • Advancements in acoustophoresis and foam fractionation methods are likely to open up new growth opportunities for biopharmaceutical companies
  • Demand for new biotherapeutics with smaller molecular weight is expected to rise among biopharmaceutical manufacturers and contract research organizations in Asia Pacific

WILMINGTON, Del., Jan. 18, 2023 /PRNewswire/ -- An analysis of recent downstream processing market trends indicate that advancement in purification technologies led to improvements in yield of protein and other drug products. Demand for platform-based purification solutions among end-users is likely to generate significant opportunities for solution providers. The global market is projected to grow at a CAGR of ~13% from 2020 to 2030, and surpass US$ 25.4 Bn by 2030.

TMR_Logo

Applications of single-use chromatography columns and membrane absorbers have increased in purification and recovery of drug products. Adoption of these downstream processing products is likely to augment the downstream processing market value in the next few years. Increase in preference for small-scale, single-use systems (capacity of 100-500 liters) is expected to create lucrative opportunities for downstream processing equipment manufacturers.

Key Findings of Study

  • Increase in Demand for Single-use Systems Among Biopharmaceutical Companies: Single-use chromatography columns are gaining traction among biopharmaceutical and biotech companies. Furthermore, rise in usage of mixed-mode and multimode chromatography resins has simplified downstream processing.
  • Adoption of Advanced Purification Technologies for Vaccines & Monoclonal Antibodies: Vaccine manufacturers are adopting advanced purification technologies to enhance their yield. Increase in production of monoclonal antibodies and antibody drug conjugate (ADCs) components is generating substantial revenues for solution providers in the market.
  • Rise in Demand for Platform-based Purification Solutions among Vaccine & Drug Manufacturers: Companies are likely to innovate in affinity chromatography technologies in order to help biopharmaceutical companies meet regulatory requirements. They are unveiling products including microbial fermentation systems that will assist end-users achieve economies of scale in downstream processing, which will help drive the downstream processing market development in the coming years. Besides, rise in demand for platform-based purification solutions for protein purification is likely to create abundant opportunities for solution providers. Increase in R&D microfluidic transduction modules is anticipated to expand opportunities for market players. A case in point is increased usage of advanced label-free microfluidic methods in downstream analysis of cells.

Request to Sample PDF of this Strategic Report (Use Corporate Mail ID for Top Priority):https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=58695

Key Drivers

  • Increase in global burden of chronic diseases is a key factor driving demand for novel biotherapeutics including vaccines
  • Rapid growth of the biopharmaceutical industry is fuelling commercialization of advanced downstream processing technologies
  • Increase in R&D spending on microfluidic platforms to develop precision technologies for gene delivery is likely to expand the downstream processing market outlook
  • Increase in demand for personalized therapies is expected to open up new revenue streams in the downstream processing market

Regional Growth Dynamics

  • The downstream processing market report found that North America held major share of the global downstream processing market in 2019. Significant research spending on biopharmaceutical products is likely to spur demand for downstream processing in the region.
  • The market in Asia Pacific is likely to be fueled by rapid expansion of the biopharmaceutical industry in emerging Asian economies. Increase in applications of ligand technologies in vaccines manufacturing is likely to create huge prospects for solution providers in Asia Pacific. For instance, COVID-19 vaccine manufacturers are seeking advanced ligand technologies.

Buy this Premium Research Report | Immediate Delivery Available - https://www.transparencymarketresearch.com/checkout.php?rep_id=58695<ype=S

Competition Landscape

Key players in the market are offering technologies that can simplify downstream processing for contract research organizations and biopharmaceutical companies in order to consolidate their position. Prominent companies in the market include Boehringer Ingelheim International GmbH, Eppendorf AG, Lonza Group, Thermo Fisher Scientific Inc., 3M Company, Sartoris Stedim Biotech S.A., Merck KGaA, and Danaher Corporation.

Segmentation

Technique

  • Purification
  • Solid-Liquid Separation
  • Clarification/Concentration

Product

  • Chromatography Columns & Resins
  • Filters
  • Membrane Absorbers
  • Single-use Products
  • Others

Application

  • Monoclonal Antibody Production
  • Vaccine Production
  • Insulin Production
  • Immunoglobulin Production
  • Erythropoietin Production
  • Others

End-user

  • Biopharmaceutical Manufacturers
  • Contract Manufacturing Organizations

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=58695

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Gene Vector Market

Micro-RNA Market

Cell Lysis & Disruption Market

DNA and Gene Cloning Services Market

Mice Model Generation Market

Cancer Biomarkers Market

Analytical Standards Market

Mice Model Technologies Market

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/downstream-processing-market-to-exceed-us-25-4-billion-by-2030-reveals-transparency-market-research-inc-301723608.html

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2023 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.